[Hypertension in the elderly: What we need to know].

Hipertensión del anciano: qué debemos conocer.
Hipertensión sistólica aislada Hipotensión ortostática Isolated systolic hypertension Orthostatic hypotension Rigidez vascular y fragilidad Vascular stifness and fragility

Journal

Hipertension y riesgo vascular
ISSN: 1989-4805
Titre abrégé: Hipertens Riesgo Vasc
Pays: Spain
ID NLM: 101510649

Informations de publication

Date de publication:
Historique:
received: 01 07 2020
revised: 12 09 2020
accepted: 22 10 2020
pubmed: 27 11 2020
medline: 16 12 2021
entrez: 26 11 2020
Statut: ppublish

Résumé

More than two thirds of people over 65 are hypertensive. Along with the high prevalence, hypertension is associated by comorbidities that originates a heterogeneous elderly population in relation to their autonomy and functional capacity. At this age, hypertension has special characteristics that make its management difficult, highlighting by isolated systolic hypertension due to the vascular stiffness typical of aging. Although decision-making is based on the clinical measurement of blood pressure, it is known that in the elderly pressure is subject to numerous influences: temporal (absence of night dipping), of the environment (exacerbation of the white coat phenomenon) and of the position (orthostatic hypotension). These circumstances must be taken into account when evaluating and deciding on therapy. At this age, there is sufficient evidence that treatment reduces both cardiovascular morbimortality and all-cause mortality.

Identifiants

pubmed: 33239263
pii: S1889-1837(20)30093-3
doi: 10.1016/j.hipert.2020.10.001
pii:
doi:

Types de publication

Journal Article Review

Langues

spa

Sous-ensembles de citation

IM

Pagination

91-98

Informations de copyright

Copyright © 2020 SEH-LELHA. Publicado por Elsevier España, S.L.U. All rights reserved.

Auteurs

P Fernández-Llama (P)

Unidad de Hipertensión y Prevención de Daño Renal, Servicio de Nefrología, Fundació Puigvert, Universitat Autònoma de Barcelona (UAB), Institut d'Investigació Biomèdica Sant Pau, Barcelona, España. Electronic address: pfernandezllama@fundacio-puigvert.es.

N Ayasreh (N)

Unidad de Hipertensión y Prevención de Daño Renal, Servicio de Nefrología, Fundació Puigvert, Universitat Autònoma de Barcelona (UAB), Institut d'Investigació Biomèdica Sant Pau, Barcelona, España.

F Calero (F)

Unidad de Hipertensión y Prevención de Daño Renal, Servicio de Nefrología, Fundació Puigvert, Universitat Autònoma de Barcelona (UAB), Institut d'Investigació Biomèdica Sant Pau, Barcelona, España.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH